Cysteamine revisited: repair of arginine to cysteine mutations
- 22 June 2017
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 40 (4) , 555-567
Abstract
Cysteamine is a small aminothiol endogenously derived from coenzyme A degradation. For some decades, synthetic cysteamine has been employed for the treatment of cystinosis, and new uses of the drug continue to emerge. In this review, we discuss the role of cysteamine in cellular and extracellular homeostasis and focus on the potential use of aminothiols to reconstitute the function of proteins harboring arginine (Arg) to cysteine (Cys) mutations, via repair of the Cys residue into a moiety that introduces an amino group, as seen in basic amino acid residues Lys and Arg. Cysteamine has been utilized in vitro and ex vivo in four different genetic disorders, and thus provides “proof of principle” that aminothiols can modify Cys residues. Other aminothiols such as mercaptoethylguanidine (MEG) with closer structural resemblance to the guanidinium moiety of Arg are under examination for their predicted enhanced capacity to reconstitute loss of function. Although the use of aminothiols holds clinical potential, more studies are required to refine specificity and treatment design. The efficacy of aminothiols to target proteins may vary substantially depending on their specific extracellular and intracellular locations. Redox potential, pH, and specific aminothiol abundance in each physiological compartment are expected to influence the reactivity and turnover of cysteamine and analogous drugs. Upcoming research will require the use of suitable cell and animal models featuring Arg to Cys mutations. Since, in general, Arg to Cys changes comprise about 8% of missense mutations, repair of this specific mutation may provide promising avenues for many genetic diseases.Keywords
Funding Information
- Qatar Foundation (7-355-3-088)
This publication has 104 references indexed in Scilit:
- Glutathione imbalance in patients with X-linked adrenoleukodystrophyMolecular Genetics and Metabolism, 2013
- Understanding the p K a of Redox Cysteines: The Key Role of Hydrogen BondingAntioxidants & Redox Signaling, 2013
- Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapyProceedings of the National Academy of Sciences, 2012
- Analysis and Functional Prediction of Reactive Cysteine ResiduesJournal of Biological Chemistry, 2012
- Structural Characterization of Inhibitors with Selectivity against Members of a Homologous Enzyme FamilyChemical Biology & Drug Design, 2011
- Thiol-Based Redox Switches and Gene RegulationAntioxidants & Redox Signaling, 2011
- Measurement of sulfur-containing compounds involved in the metabolism and transport of cysteamine and cystamine. Regional differences in cerebral metabolismJournal of Chromatography B, 2009
- Mouse models of cystathionine β‐synthase deficiency reveal significant threshold effects of hyperhomocysteinemiaThe FASEB Journal, 2008
- Hereditary Pancreatitis Caused by a Novel PRSS1 Mutation (Arg-122 → Cys) That Alters Autoactivation and Autodegradation of Cationic TrypsinogenJournal of Biological Chemistry, 2002
- Oxidation and Generation of Hydrogen Peroxide by Thiol Compounds in Commonly Used Cell Culture MediaBiochemical and Biophysical Research Communications, 2001